Publication Date
2023
Abstract
The goal of our project is to develop a new measure of chemotherapeutic drug binding in pancreatic cancer. We will use x-ray diffraction (XRD) and paired-agent x-ray fluorescence (PA-XRF). These tools will help to quantify chemotherapy binding and extracellular matrix. This process will help to assess cancer cells resistance and abnormal collagen growth (density) to then further be restricted. This restriction will allow the chemotherapeutic drug to penetrate the cancerous tumor and become more effective.
Rights
Copyright is owned by the creators of this work.
Recommended Citation
Williams, Jasmine, "Analyzing Collagen Density of ECM & Chemo-Drug Binding Using XRD in Pancreatic Cancer Slices with ECM Remodeling Drug & PA-XRF" (2023). Parkland Science Scholars. 1.
https://spark.parkland.edu/science_scholars/1
